• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Abbott Labs Has the Formula for a Long Trade

ABT has made an upside breakout on the daily Point and Figure chart, and here's how investors can make their next move.
By BRUCE KAMICH
Jan 26, 2021 | 11:49 AM EST
Stocks quotes in this article: BA, ABT, FB, AAPL, TSLA

During Friday's "Mad Money" program, Jim Cramer gave viewers his game plan for this week. On Wednesday, we'll hear from the Federal Reserve, but Cramer wasn't expecting any changes. The earnings continue with Boeing  (BA)  and Abbott Labs (ABT)  two stocks that are still early in their rallies. After the close, it's a trifecta of tech darlings, Facebook (FB) , Apple (AAPL) and Tesla  (TSLA) .

 
Let's check out the charts of ABT first.  
 
In this daily bar chart of ABT, below, we can see that prices are very close to breaking above the highs of August and November. ABT is trading above the rising 50-day moving average line and the rising 200-day moving average line. The trading volume has remained steady the past five months instead of diminishing and that I consider a positive sign. The On-Balance-Volume (OBV) line has been moving up since early December and is close to making a new high. The Moving Average Convergence Divergence (MACD) oscillator gave us an outright buy signal earlier this month when it crossed above the zero-line. 
 
 
 
In this weekly bar chart of ABT, below, we see a constructive picture. Prices are in an uptrend above the rising 40-week moving average line. The weekly OBV line has been moving up since early December and is close to making a new high. The MACD oscillator showed weakness from November but has recently narrowed and is close to an upside crossover and buy signal. 
 
 
 
 
In this daily Point and Figure chart of ABT, below, we can see that prices just made an upside breakout at $115.37 and a $125 price target is being projected.
 
 
 
Bottom line strategy: ABT has made an upside breakout on the daily Point and Figure chart (above). Traders could use available weakness to go long. Risk a decline to $107. The $125 area is our first price objective. 
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Technical Analysis | Pharmaceuticals | Mad Money

More from Investing

Bearish Bets: 2 Recently Hot Stocks You Should Consider Shorting This Week

Bob Lang
Mar 7, 2021 10:30 AM EST

These Nasdaq names are displaying both quantitative and technical deterioration.

Dividend Hunters Will Like the Combination Found in Global Medical REIT Shares

Chris Versace
Mar 7, 2021 9:00 AM EST

More people seeking more healthcare and medical attention will create a rising tide for GMRE's addressable market.

The Psilocybin Patent Race Is On

Debra Borchardt
Mar 6, 2021 12:30 PM EST

It feels like these companies are casting a wide net, but it makes sense to file at the beginning of this mushroom mania.

The Challenge of Short Selling

James "Rev Shark" DePorre
Mar 6, 2021 10:00 AM EST

Short selling is a powerful tool, but it is not just the inverse of going long and requires a very different mindset to do it effectively.

Kass: There Are Many Reasons to Be a Bear

Doug Kass
Mar 6, 2021 8:15 AM EST

I believe the markets are headed lower - probably not in a straight line or as steep as the last few days, but in a saw tooth fashion lower.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:38 AM EST GARY BERMAN

    The INDU and DIA

    FIBOCALL: The INDU index and the DIA The INDU ...
  • 10:44 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    "The Challenge of Short-Selling"
  • 08:40 AM EST PAUL PRICE

    Recent Pick SpartanNash (SPTN) Raised Its Quarterly Payout by 3.9%

  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login